December 1, 2025 · Form 4 insider transaction
Pizzuti Dana bought 5,000 shares of Crinetics Pharmaceuticals, Inc. at $16.89 per share, a transaction worth $84.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Includes 567 shares acquired under the Issuer's Employee Stock Purchase Plan.